Cinemark Holdings, Inc.
Cinemark operates movie theaters in the United States and Latin America, serving moviegoers and providing a distribution channel for studios and other content providers. As of December 31, 2025, it operated 496 theaters and 5,637 screens across 42 U.S. states and 13 Latin American countries. Its reportable segments are U.S. markets and international markets. Cinemark shows mainstream films, alternative and special-event content, and, in some Latin American markets, local films. Its premium formats include XD, IMAX and ScreenX. Cinemark earns money from movie admissions, food and beverage and merchandise sales, screen advertising, and other offerings. It also receives advertising-related fees and revenue shares, and monetizes theaters through options such as private events. Its U.S. theaters participate in National CineMedia’s Noovie advertising network, while Flix Media handles screen advertising in Latin America. Cinemark is headquartered in Plano, Texas.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CNK in the last 30 days.
See all $CNK insider activity →Macquarie kept its Outperform rating on Cinemark (CNK) but raised its price target to $48 from $47, suggesting a 19.9% upside from the Nov 5 close of $40.04. Recent analyst price targets for CNK range from $41 to $50.
Analysts made several rating changes: BMO initiated Astera Labs (ALAB) with an outperform and $375 target. KeyBanc upgraded MYR Group (MYRG) to overweight with a $361 target. Morgan Stanley upgraded Acadian (AAMI) to overweight and downgraded Cisco (CSCO) to equal weight. Deutsche Bank upgraded JetBlue (JBLU) and Frontier to buy. Truist downgraded Nike (NKE) to sell with a $29 target. Citi initiated ATI with a buy rating and $229 target. Compass Point upgraded Circle (CRCL) to buy.
Analysts upgraded Cinemark (CNK), First Solar (FSLR), JetBlue (JBLU), and others; downgraded Cisco (CSCO), Dollar Tree (DLTR), HubSpot (HUBS), and others. Markets mixed post-election, with Dow up 3.03%, S&P 500 up 1.58%, and Nasdaq up 1.44%.
Over the past 7 days, AlphAI's AI scored 31 news stories mentioning CNK (Cinemark Holdings, Inc.). Coverage has skewed bullish: 22 bullish, 6 neutral, and 3 bearish.
Recent CNK coverage spans financial news and earnings.
The target raise suggests modest upside potential for the stock.
Overweight rating may support price.
Potential upside as analysts raise rating.
The upgrade and higher target suggest near‑term upside as investors reprice the stock.
Target price cut suggests potential downside pressure on CNK.
AlphAI scores every news story that mentions CNK with an AI model for sentiment and relevance, and aggregates insider trades from Cinemark Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Macquarie kept its Outperform rating on Cinemark (CNK) but raised its price target to $48 from $47, suggesting a 19.9% upside from the Nov 5 close of $40.04. Recent analyst price targets for CNK range from $41 to $50.
Analysts made several rating changes: BMO initiated Astera Labs (ALAB) with an outperform and $375 target. KeyBanc upgraded MYR Group (MYRG) to overweight with a $361 target. Morgan Stanley upgraded Acadian (AAMI) to overweight and downgraded Cisco (CSCO) to equal weight. Deutsche Bank upgraded JetBlue (JBLU) and Frontier to buy. Truist downgraded Nike (NKE) to sell with a $29 target. Citi initiated ATI with a buy rating and $229 target. Compass Point upgraded Circle (CRCL) to buy.
Analysts upgraded Cinemark (CNK), First Solar (FSLR), JetBlue (JBLU), and others; downgraded Cisco (CSCO), Dollar Tree (DLTR), HubSpot (HUBS), and others. Markets mixed post-election, with Dow up 3.03%, S&P 500 up 1.58%, and Nasdaq up 1.44%.
Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.
Argus lowered its price target for Cinemark Holdings Inc (CNK) to $40.00. The company operates movie theaters in the U.S. CNK's earnings estimate is $40.38. This update may impact investor sentiment and trading decisions.
Wells Fargo kept its Equal-Weight rating on Cinemark Holdings but raised its price target to $42 from $34, suggesting a 9.1% upside from the Nov 3 close of $38.51. Recent analyst price targets for the company range from $41 to $46.
StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.
Wedbush reaffirmed its Outperform rating for Cinemark Holdings and increased its price target to $46 from $45, suggesting a 19.4% upside from the Nov 3 close of $38.51. Recent analyst targets for the company range from $41 to $45.
Cinemark Holdings (CNK) indicated capital expenditures may exceed $250M due to expansion of premium formats and new builds. The company is investing in enhancing its theater offerings.
Analysts raised Cinemark Holdings' 12-month price target from $42.23 to $42.62, with a range of $34 to $48. The new target suggests 10% upside from the Nov. 2 closing price. All 13 analysts maintain a 'Buy' consensus rating, with 8 Buys and 5 Holds.
